Change From Baseline in Saint-George's Respiratory Questionnaire (SGRQ) Total Score at 52 Weeks;Time to First Acute Idiopathic Pulmonary Fibrosis (IPF) Exacerbation;Absolute Change From Baseline in Forced Vital Capacity (FVC) Over 52 Weeks;Relative Change From Baseline in Forced Vital Capacity (FVC) Over 52 Weeks;Absolute Change From Baseline in Forced Vital Capacity (FVC) (% Predicted) Over 52 Weeks;Relative Change From Baseline in Forced Vital Capacity (FVC) (% Predicted) Over 52 Weeks;Absolute Categorical Change of FVC (% Predicted) by Categories Over 52 Weeks - 5% Threshold;Absolute Categorical Change of FVC (% Predicted) by Categories Over 52 Weeks - 10% Threshold;FVC Responders Using 10% Threshold at 52 Weeks;Proportion of FVC Responders Using 5% Threshold at 52 Weeks;Proportion of SGRQ Responders at 52 Weeks: Patient Reported Outcomes (PROs);Change From Baseline in SGRQ Symptom Score at 52 Weeks: Patient Reported Outcomes (PROs);Change From Baseline in SGRQ Impact Score at 52 Weeks (Points): Patient Reported Outcomes (PROs);Change From Baseline in SGRQ Activity Score at 52 Weeks (Points): Patient Reported Outcomes (PROs);Change From Baseline in Idiopathic Pulmonary Fibrosis (IPF) Specific Version of SGRQ (SGRQ-I) Total Score at 52 Weeks (Points): Patient Reported Outcomes (PROs);Change From Baseline in Shortness of Breath Questionnaire (SOBQ) at 52 Weeks: Patient Reported Outcomes (PROs);Change From Baseline in Cough Symptoms Score of the Cough and Sputum Assessment Questionnaire (CASA-Q) Score at 52 Weeks: Patient Reported Outcomes (PROs);Change From Baseline in Cough Impact Score of the Cough and Sputum Assessment Questionnaire (CASA-Q) Score at 52 Weeks : Patient Reported Outcomes (PROs);Proportion of Patient's Global Impression of Change (PGI-C) Responders at 52 Weeks: Patient Reported Outcomes (PROs);Change From Baseline in EuroQol 5-Dimensional Quality of Life Questionnaire (EQ-5D) Health State up to 52 Weeks : Patient Reported Outcomes (PROs);Risk of an Acute IPF Exacerbation Over 52 Weeks;Time to Death Over 52 Weeks;Time to Death Due to Respiratory Cause Over 52 Weeks (Adjudicated);Time to On-treatment Death;Time to Death or Lung Transplant Over 52 Weeks;Time to Death or Lung Transplant or Qualifying for Lung Transplant Over 52 Weeks.;Change From Baseline in SpO2 (Oxygen Saturation, Expressed in Percent) at Rest up Over 52 Weeks;Change From Baseline in Carbon Monoxide Diffusion Capacity (DLCO) at Rest Over 52 Weeks